Skip to main content
ILSUNG IS CO., LTD. logo

ILSUNG IS CO., LTD. — Investor Relations & Filings

Ticker · 003120 ISIN · KR7003120003 KO Manufacturing
Open in API
Filings indexed 212 across all filing types
Latest filing 2020-03-09 Director's Dealing
Country KR South Korea
Listing KO 003120

About ILSUNG IS CO., LTD.

https://www.ilsung.com/

ILSUNG IS CO., LTD. is a pharmaceutical company specializing in the development and manufacturing of therapeutic products. The company's core portfolio is focused on antibiotics, cardiovascular agents, anesthetics, and contrast media. It is actively expanding its research and development into new therapeutic areas, including treatments for gastrointestinal (GI), central nervous system (CNS), and other cardiovascular (CV) conditions.

Recent filings

Filing Released Lang Actions
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Financial Supervisory Service in South Korea. It details the share transactions (specifically a sale of shares) by an executive (Director Yoon Deok-geun) of Ilsung Pharmaceuticals. This type of filing is a standard disclosure of insider trading/director dealings.
2020-03-09 Korean
주주총회소집공고
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a '주주총회소집공고' (Notice of Convocation of General Meeting of Shareholders) for Ilsung Pharmaceuticals. It contains the meeting agenda, details on director and auditor nominations, and financial statements for the 60th fiscal year. This type of document is provided to shareholders to inform them of upcoming meeting items and to solicit their votes, which falls under the category of Proxy Solicitation & Information Statement.
2020-03-05 Korean
최대주주등소유주식변동신고서
Director's Dealing Classification · 100% confidence The document is a 'Report of Changes in Shareholding by Major Shareholders' (최대주주등소유주식변동신고서) for Il-Sung Pharmaceutical. It details specific transactions (sales) made by a company executive (Yoon Deok-geun) and provides a comprehensive table of share ownership for all major shareholders. This falls under the category of 'Director's Dealing' (DIRS) as it reports personal share transactions by company directors and executives.
2020-03-03 Korean
주주총회소집결의
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a formal notice of a General Meeting of Shareholders (주주총회소집결의) issued by Il-Sung Pharmaceuticals. It outlines the date, location, and agenda items (financial statement approval, director appointments, and remuneration limits) for the upcoming Annual General Meeting. This type of document is a standard proxy solicitation and information statement provided to shareholders to inform them of meeting details and agenda items, which falls under the Proxy Solicitation & Information Statement category.
2020-03-02 Korean
주주총회집중일개최사유신고
AGM Information Classification · 98% confidence The document is a short regulatory filing (544 characters) submitted by Il-Sung Pharmaceutical to report the reason for holding their Annual General Meeting (AGM) on a 'concentrated date' (a date when many companies hold their AGMs). It is a formal regulatory notification regarding meeting logistics rather than the AGM presentation materials themselves or a proxy statement. As it is a specific regulatory disclosure regarding meeting scheduling, it falls under the general regulatory filing category.
2020-03-02 Korean
현금ㆍ현물배당결정
Notice of Dividend Amount Classification · 100% confidence The document is a formal announcement from Il-Sung Pharmaceutical regarding a decision on cash dividends. It specifies the dividend amount per share, the dividend record date, and the date of the board resolution. This fits the definition of a 'Notice of Dividend Amount' (DIV) as it provides specific details regarding dividend payments to shareholders.
2020-03-02 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.